Literature DB >> 31531176

Tranexamic Acid for Melasma: Evaluating the Various Formulations.

Jordan V Wang1,2, Nikita Jhawar1,2, Nazanin Saedi1,2.   

Abstract

Melasma is a common dermatological condition that can be notoriously difficult to treat. Topical bleaching agents and strict photoprotection, in addition to adjuvant treatment modalities, such as chemical peels and laser treatments, have been shown to provide only minimal improvements in the condition. Recently, tranexamic acid has shown promise. Topical, intradermal, and oral formulations of tranexamic acid have been studied, with oral formulations demonstrating the greatest, albeit temporary, improvement. In this brief review, we discuss the different formulations of tranexamic acid for melasma and offer suggestions for future directions of research.

Entities:  

Keywords:  Aesthetics; dermatology; melasma; skincare; tranexamic acid

Year:  2019        PMID: 31531176      PMCID: PMC6715124     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  2 in total

1.  The High Content of Ent-11α-hydroxy-15-oxo-kaur- 16-en-19-oic Acid in Adenostemma lavenia (L.) O. Kuntze Leaf Extract: With Preliminary in Vivo Assays.

Authors:  Akie Hamamoto; Ryosuke Isogai; Miwa Maeda; Masumi Hayazaki; Eito Horiyama; Shigeo Takashima; Mamoru Koketsu; Hiroshi Takemori
Journal:  Foods       Date:  2020-01-09

2.  Targeting delivery and minimizing epidermal diffusion of tranexamic acid by hyaluronic acid-coated liposome nanogels for topical hyperpigmentation treatment.

Authors:  Ying Liu; Yue Han; Tingting Zhu; Xianglei Wu; Wenxin Yu; Jiafang Zhu; Ying Shang; Xiaoxi Lin; Tianlan Zhao
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.